Cancer Journey


VIDEOS

Case Based Panel Discussion - Stage 3 NSCLC Best Schedule - Durvalumab/Imfinzi in Varying Patients

Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...

Case Based Panel Discussion - Stage 3 NSCLC Treatment Standard and the Risk of Potential Pneumonitis

Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...

Case Based Panel Discussion Stage 3 NSCLC - Does Timing of Treatment Make a Difference in Response

Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...

Case Based Panel Discussion - Unresectable NSCLC, In a Frail Patient with Competing Risks, Is the Standard Treatment the Best Approach?

Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding...

OncTalk 2018 - Local Therapies for Metastatic Lung Cancer - Who, What, Why, When and How?

On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a discussion on Local Therapies for Metastatic Lung Cancer...

ARTICLES

Broadening the Concept of the Precocious Metastasis to Define When Local Therapy Makes Sense for Metastatic Cancer
From the Grace Archives | Originally Published April 6, 2012 | By Dr West A couple of nights ago, I was at a “journal club” discussion with several of...
Can “Local” Therapy in Metastatic Lung Cancer Alter the Path for Systemic Disease?

After completing my unpacking from ASCO and beginning to see a path of light as I dig out from under the backup of work that accumulated, I wanted to...

Have Your Practices Changed Regarding Prophylactic Cranial Irradiation for Extensive Stage SCLC Patients?

Drs. Ben Solomon, Leora Horn, & Jack West discuss whether the data highlighting cognitive deficits from whole brain radiation therapy (WBRT) for patients with brain metastases should change our recommendations for prophylactic cranial irradiation (PCI).

What Are Your Current Practices for Consolidation Chest Radiation for Extensive SCLC?

Drs. Leora Horn, Ben Solomon, & Jack West debate whether results from a European trial of chest radiation after chemotherapy for extensive stage small cell lung cancer should lead to a change in treatment for this setting.

What is the Value of Testing for Molecular Markers in Advanced NSCLC?

Memorial Sloan-Kettering Cancer Center medical oncologist Dr. Greg Riely explains how testing for specific mutations in patients with advanced NSCLC can guide prognosis and treatment recommendations.

ONLINE COMMUNITY

Silibinin effective for brain metastases in lung cancer

This seems to be an option for everyone with brain metastases (inform your doctor as it is quite new) ) Here are links to research done in Spain in...

RECENT POSTS

Need help adrenal metastasis from stable multifocal nsclc
Hi Carole, Welcome to Grace…
Last Comment by Carolesc on Dec 4, 2021 3:07 pm
Tough decision between a whole brain radiation vs occipital craniotomy
Thinking of you
Last Comment by scohn on Oct 9, 2018 1:03 pm
Tough decision between a whole brain radiation vs occipital craniotomy
Thank you so much for your
Last Comment by scohn on Oct 9, 2018 1:03 pm
Tough decision between a whole brain radiation vs occipital craniotomy
I think that question is
Last Comment by scohn on Oct 9, 2018 1:03 pm
Tough decision between a whole brain radiation vs occipital craniotomy
What is a lateral ventricle transependymal extension of tumor?
Last Comment by scohn on Oct 9, 2018 1:03 pm

Case Based Panel Discussion - 2019 ALK Positive with Brain Mets, Radiation before ALK Inhibitor?

Video
For this round of case based panel discussions, Dr. Jack West is joined by Drs. Jonathan Riess and Suki Padda.

Jonathan W. Riess, MD MS is Associate Professor of Medicine in the Division of Hematology/Oncology at UC Davis Comprehensive Cancer Center.

Sukhmani Padda MD is Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center.

Case Based Panel Discussion - Stage 3 NSCLC Best Schedule - Durvalumab/Imfinzi in Varying Patients

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion - Stage 3 NSCLC Treatment Standard and the Risk of Potential Pneumonitis

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion Stage 3 NSCLC - Does Timing of Treatment Make a Difference in Response

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC.

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Case Based Panel Discussion - Unresectable NSCLC, In a Frail Patient with Competing Risks, Is the Standard Treatment the Best Approach?

Video
Dr. Jack West recently had the privilege to spend time with Drs. Millie Das and Matthew Gubens for a series of case-based discussions regarding unresectable NSCLC .   

Dr. Millie Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and also leads the VA thoracic tumor board on a biweekly basis.

Videos now posted! OncTalk 2018 - Local Therapies for Metastatic Lung Cancer - Who, What, Why, When and How?

Discussion Topic
General Lung/Thoracic Cancer
On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a live and webcast discussion on Local Therapies for Metastatic Lung Cancer. We are pleased to be able to share with you the videos from the live webcast, available now.  View the videos here! 

Drs. Jack West, Vivek Mehta, Puneeth Iyengar, and Eric Vallieres discussed the following topics: 

~Newer Technologies in Radiation

Operations Director for GRACE. Have worked with cancerGRACE.org since July 2009.  Became involved as a caregiver to my best friend, and quickly came to see that GRACE is filling a need in the area of cancer education. 

OncTalk 2018 - Local Therapies for Metastatic Lung Cancer - Who, What, Why, When and How?

Video

On Saturday, November 10, 2018, GRACE partnered with Swedish Cancer Institute to present a discussion on Local Therapies for Metastatic Lung Cancer. We are pleased to share with you the videos from the live webcast.

 

Our faculty discussed the following topics: 

~Newer Technologies in Radiation

~Novel Indications for Local Therapy in Advanced NSCLC

~The Growing Potential Utility of Surgery in Advanced NSCLC

~Systemic Therapies for Advanced NSCLC

~Panel Discussion and Q&A

  

Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?

Discussion Topic
Stage IV NSCLC

Hi Grace Members,

Grace is happy to present in partnership with the Swedish Cancer Institute " Local Therapies for Metastatic Lung Cancer Who, What, Why, When and How?"  this Saturday, November 10, 2018 | 10:00 am– 1:00 pm Pacific time.   This seminar will be available at no charge in person and as a live webinar.

I joined GRACE as a caregiver for my husband who had a Pancoast tumor, NSCLC stage III in 2009. He had curative chemo/rads then it was believed he had a recurrence in the spine/oligometastasis that was radiated. He's 10 years out from treatment.
Subscribe to Radiation Therapy